Keywords: mmd/teva, agreement, marion, merrell, dow, teva, pharmaceutical

MMD/Teva Agreement

Article | 20 March 1995

- Marion Merrell Dow and Teva Pharmaceutical have signed an agreement to collaborate in marketing the multiple sclerosis treatment Copaxone (copolymer 1) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Copaxone

Glatiramer Acetate

Go to drug listing